Zobrazeno 1 - 10
of 152
pro vyhledávání: '"Flavia, Longo"'
Publikováno v:
Clinical Management Issues, Vol 4, Iss 1S, Pp 3-7 (2015)
We report the case of a 51-year-old woman with limited Small Cell Lung Cancer (SCLC). Cytological diagnosis has been made by fibroscopy. Chemotherapy schedule was cisplatin 30 mg/mq and VP-16 100 mg/mq days 1,2,3 q21 as first line treatment. The seru
Externí odkaz:
https://doaj.org/article/b25af28d89884b4b849884a47f771108
Autor:
Eleonora Timperi, Chiara Focaccetti, Daniela Gallerano, Mariangela Panetta, Sheila Spada, Enzo Gallo, Paolo Visca, Federico Venuta, Daniele Diso, Arsela Prelaj, Flavia Longo, Francesco Facciolo, Paola Nisticò, Vincenzo Barnaba
Publikováno v:
OncoImmunology, Vol 6, Iss 7 (2017)
IL-18 is an inflammasome-related cytokine, member of the IL-1 family, produced by a wide range of cells in response to signals by several pathogen- or damage-associated molecular patterns. It can be highly represented in tumor patients, but its relev
Externí odkaz:
https://doaj.org/article/3a3aab95fc704fc39842f0e2c0df917d
Autor:
Arsela Prelaj, Sara Elena Rebuzzi, Gabriella Del Bene, Julio Rodrigo Giròn Berrìos, Alessandra Emiliani, Lucilla De Filippis, Alessandra Anna Prete, Silvia Pecorari, Gaia Manna, Carla Ferrara, Daniele Rossini, Flavia Longo
Publikováno v:
ERJ Open Research, Vol 3, Iss 1 (2017)
In small-cell lung cancer (SCLC), the role of chemotherapy and radiotherapy is well established. Large-cell neuroendocrine carcinoma (LCNEC) shares several clinicopathological features with SCLC, but its optimal therapy is not defined. We evaluated c
Externí odkaz:
https://doaj.org/article/fbf069b64a824bdca1f7b358061bc685
Autor:
Gian Paolo Spinelli, Rosalba Caccavale, Carmela Martire, Ilenia Cammarata, Paolo Visca, Sheila Spada, Felice Giangaspero, Paola Nisticò, Silvia Piconese, Silverio Tomao, Chiara Focaccetti, Fabiana Letizia Cecere, Gabriella Girelli, Julio Rodrigo Giròn Berrìos, Flavia Longo, Federica Buzzacchino, Carmine Mancone, Marino Paroli, Giovanna Peruzzi, Vincenzo Barnaba, Marta Buccilli, Mariangela Panetta, Alessio Grimaldi, Nicoletta D'Alessandris, Francesco Facciolo
Publikováno v:
Communications Biology, Vol 3, Iss 1, Pp 1-13 (2020)
Communications Biology
Communications Biology
Here, we developed an unbiased, functional target-discovery platform to identify immunogenic proteins from primary non-small cell lung cancer (NSCLC) cells that had been induced to apoptosis by cisplatin (CDDP) treatment in vitro, as compared with th
Publikováno v:
Clinical Management Issues, Vol 3, Iss 2, Pp 63-69 (2009)
We report the case of a 53-year-old woman with brain metastatic Non-Small Cell Lung Cancer (NSCLC). Diagnosis was made during brain surgery. Brain metastases were treated both with surgery and radiotherapy. The chemotherapy schedule was cisplatin 75
Externí odkaz:
https://doaj.org/article/7b6a7d562f574e438fb6436bb9ab7b8f
Autor:
Flavia Longo, Daniele Gianfrilli, Antongiulio Faggiano, Laura Rizza, Marta Tenuta, Emilia Sbardella, Andrea Lenzi, Elisa Giannetta, G. Del Bene, Rosa Lauretta, Carlotta Pozza
Publikováno v:
Endocrine. 67:597-604
Hypothyroidism is a common side effect of Sunitinib (SUN) treatment in metastatic renal cell carcinoma (mRCC) patients. We aimed to evaluate thyroid profile during the alternative 2/1 SUN treatment schedule and to assess the predictive value of hypot
Autor:
Daniele Rossini, Salvatore Caponnetto, Vittoria Lapadula, Lucilla De Filippis, Gabriella Del Bene, Alessandra Emiliani, Flavia Longo
Publikováno v:
Case Reports in Oncological Medicine, Vol 2013 (2013)
Merkel cell carcinoma (MCC) is an extremely rare primary neuroendocrine neoplasm of the skin that shows aggressive behavior and a poor prognosis. We report a case of a 67-year-old male with a Merkel cell carcinoma which initially presented itself as
Externí odkaz:
https://doaj.org/article/4ec5f60910db4d42bd59e304cd4549ad
Autor:
Giacomo Cartenì, Filippo de Marinis, Flavia Longo, Gianpiero Fasola, Domenico Galetta, Alberto Caprioli, Dario Giuffrida, Alberto Zaniboni, Valentina Acciai, Oscar Alabiso, Maria Rita Migliorino, Antonio Santo, Antonio Pazzola, Diego Cortinovis, Giampiero Romano, Sabrina Vari
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 143:783-791
Non-small cell lung cancer (NSCLC) is a condition with significant clinical burden for patients and relevant economic impact. Limited evidence exists on the management costs of NSCLC patients, especially in the late phases of the disease. The main ob
Autor:
Gabriella Del Bene, Sara Elena Rebuzzi, Alessandra Anna Prete, Julio Rodrigo Giròn Berrìos, Daniele Rossini, Lucilla De Filippis, Flavia Longo, Carla Ferrara, Silvia Pecorari, Alessandra Emiliani, G. Manna, Arsela Prelaj
Publikováno v:
ERJ Open Research
ERJ Open Research, Vol 3, Iss 1 (2017)
ERJ Open Research, Vol 3, Iss 1 (2017)
In small-cell lung cancer (SCLC), the role of chemotherapy and radiotherapy is well established. Large-cell neuroendocrine carcinoma (LCNEC) shares several clinicopathological features with SCLC, but its optimal therapy is not defined. We evaluated c
Autor:
Silvia Pecorari, Alessandra Anna Prete, Giancarlo Troncone, Francesca Belardinilli, Marco Filetti, Edoardo Milanetti, Beatrice Cardinali, Pasquale Pisapia, Marialaura Petroni, Giuseppe Giannini, Caterina Bonfiglio, Valentina Magri, Anna Coppa, Mariarosaria Colella, Gianluca Canettieri, Matteo Santoni, Enrico Cortesi, Carlo Capalbo, Arianna Nicolussi, Valeria Colicchia, Umberto Malapelle, Paolo Marchetti, Domenico Raimondo, Flavia Longo, Alessandra Tessitore, Paola Infante, Silvia Mezi, Virginia Valentini, Diana Bellavia, Paola Paci
Publikováno v:
Cancers, Vol 11, Iss 2, p 147 (2019)
Cancers (Basel) 11 (2019). doi:10.3390/cancers11020147
info:cnr-pdr/source/autori:Capalbo C.; Belardinilli F.; Raimondo D.; Milanetti E.; Malapelle U.; Pisapia P.; Magri V.; Prete A.; Pecorari S.; Colella M.; Coppa A.; Bonfiglio C.; Nicolussi A.; Valentini V.; Tessitore A.; Cardinali B.; Petroni M.; Infante P.; Santoni M.; Filetti M.; Colicchia V.; Paci P.; Mezi S.; Longo F.; Cortesi E.; Marchetti P.; Troncone G.; Bellavia D.; Canettieri G.; Giannini G./titolo:A simplified genomic profiling approach predicts outcome in metastatic colorectal cancer/doi:10.3390%2Fcancers11020147/rivista:Cancers (Basel)/anno:2019/pagina_da:/pagina_a:/intervallo_pagine:/volume:11
Cancers
Volume 11
Issue 2
Cancers (Basel) 11 (2019). doi:10.3390/cancers11020147
info:cnr-pdr/source/autori:Capalbo C.; Belardinilli F.; Raimondo D.; Milanetti E.; Malapelle U.; Pisapia P.; Magri V.; Prete A.; Pecorari S.; Colella M.; Coppa A.; Bonfiglio C.; Nicolussi A.; Valentini V.; Tessitore A.; Cardinali B.; Petroni M.; Infante P.; Santoni M.; Filetti M.; Colicchia V.; Paci P.; Mezi S.; Longo F.; Cortesi E.; Marchetti P.; Troncone G.; Bellavia D.; Canettieri G.; Giannini G./titolo:A simplified genomic profiling approach predicts outcome in metastatic colorectal cancer/doi:10.3390%2Fcancers11020147/rivista:Cancers (Basel)/anno:2019/pagina_da:/pagina_a:/intervallo_pagine:/volume:11
Cancers
Volume 11
Issue 2
The response of metastatic colorectal cancer (mCRC) to the first-line conventional combination therapy is highly variable, reflecting the elevated heterogeneity of the disease. The genetic alterations underlying this heterogeneity have been thoroughl